11.01.02
Provexis has introduced CardioFlow®, a new functional ingredient for heart health. CardioFlow is a patented extract from the humble tomato, which has been shown in human trials to have an inhibitory effect on blood platelets, thereby reducing the propensity toward excessive blood clotting. After a final large scale human trial in 2003, Provexis will be seeking to complete a deal with a major brand-holding food company and it is anticipated that a new range of CardioFlow-containing “heart-healthy” products will be on the market in 2004. A “heart-healthy” orange juice is expected to be the first product launched.
For further information: 0161-226-7256.
For further information: 0161-226-7256.